- Global Locations -


Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705


Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531


Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates


Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

RNA-Targeted Small Molecules Market Overview

According to the latest research by Future Market Insights, RNA-Targeted Small Molecules market is set to witness a 6.6% growth during the year 2021-2031.

The market is a fragmented market growing at a slow rate and is anticipated to witness lucrative growth with the rising use of methodologies by major players; the market is projected to grow over the forecast period.

What is Driving Demand for RNA-Targeted Small Molecule

Factors such as development in genome mapping programs, the rising innovative developments, and increasing applications are anticipated to boost the market growth.

Moreover, technological advancements help in the market development. Technological developments has assisted analysts to collect vital information about public health and epidemiology studies, to sequence viruses and bacteria and help find causes that might add to the virulence.

Furthermore, the market is boosted by the advantages of rising number of mRNA-sequencing grants; mRNA-sequencing over traditional technologies; quick development in the precision medicine market; and increasing amount of research including RNA-seq.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Growing Number of Cancer Cases, likely to Boost RNA-Targeted Small Molecules Sales

Cancer is one of the leading cause of death across the world. As per the American Cancer Society, around 1.8 million new cancer cases were diagnosed and around 606,520 cancer deaths occurred in 2020, in the United States. Hence, rising burden of a wide range of diseases among people, worldwide, is expected to boost the demand for the market.

There has been an increase in the utilization of advanced technologies, like combinatorial chemistry, bioinformatics, and high throughput for better drug candidate detection.

US and Canada RNA-Targeted Small Molecules Market Outlook

The US and Canada RNA-Targeted Small Molecules market is projected to observe a robust growth in the market due to the rise in the presence of several cancer-relief organizations and campaigns in the US and Canada.

In addition, US has high opportunities for biosimilars, because biologics hold higher prices. By 2021, the US market is expected to be one of the main competitors of biosimilars.

Moreover, beneficial government initiatives and upsurge in number of research partnerships are few of the factors projected to upsurge market growth.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Europe Demand Outlook for RNA-Targeted Small Molecules

Europe is anticipated to be second most lucrative region for market due to various factors. The growing patient pool results into a high rate of RNA-targeted small molecules adoption due to the growing number of cancer patients.

In addition, rise in cancer patients, focus on merger and acquisition and funding by the governmental bodies by several major manufacturers is anticipated to lead to RNA-targeted small molecules market growth.

Who are the Key Manufacturers and Suppliers of RNA-Targeted Small Molecules

Some of the leading manufacturers and suppliers of RNA-Targeted Small Molecules include

The market is fragmented with presence of different major players. Technological collaborations and partnerships by the key players in the market with a vision to bridge the demand-supply gap is projected to play a major role in growth of the market.

Globally, they are involved in long term contracts with healthcare organizations, and are comprising into strategic alliances and partnerships with other players in several nations to expand their business. In addition, key manufacturers are funding extensively in the research and development to produce advanced products.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Segments

By Product & Service:

  • mRNA Translation Regulation
  • Indirect RNA Targeting – Epitranscriptomics
  • RNA Splicing Modification
  • Direct RNA Targeting

By Application:

  • Drug Discovery
  • Oncology Research
  • Disease Identification

By End User:

  • Hospitals
  • Research Laboratories
  • Contract Research Organizations
  • Pharmaceutical and Biotechnology Companies

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Explore Healthcare Insights

View Reports

RNA-Targeted Small Molecules Market

Schedule a Call